Welcome to LookChem.com Sign In|Join Free
  • or
Morpholine, 4-[2-(3-fluoro-4-nitrophenoxy)ethyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

852068-03-2

Post Buying Request

852068-03-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

852068-03-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 852068-03-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,0,6 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 852068-03:
(8*8)+(7*5)+(6*2)+(5*0)+(4*6)+(3*8)+(2*0)+(1*3)=162
162 % 10 = 2
So 852068-03-2 is a valid CAS Registry Number.

852068-03-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[2-(3-fluoro-4-nitrophenoxy)ethyl]morpholine

1.2 Other means of identification

Product number -
Other names Morpholine,4-[2-(3-fluoro-4-nitrophenoxy)ethyl]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:852068-03-2 SDS

852068-03-2Relevant academic research and scientific papers

BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE

-

Page/Page column 230, (2012/02/15)

Compounds of Formula (I) are useful inhibitors of anaplastic lymphoma kinase. Compounds of Formula (I) have the following structure: where the definitions of the variables are provided herein.

Thiazolyl-Dihydro-Indazole

-

Page/Page column 7, (2008/06/13)

The present invention encompasses compounds of general formula (1) wherein R1 to R5 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use th

FUSED HETEROCYCLIC COMPOUNDS

-

Page/Page column 105, (2008/06/13)

This invention provides fused heterocyclic compounds, pharmaceutical compositions of the compounds, and methods of using the compounds for the treatment of, inter alia, IL-12 related disease and disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 852068-03-2